ApoRepair
Primary tabs
About your organization / profile
ApoRepair, une startup en phase préclinique, a pour ambition de développer un peptide thérapeutique, first in class, qui sera administré lors de la réouverture de l’artère occluse dans l’infarctus du myocarde. Cette reperfusion myocardique, indispensable pour sauver le patient, génère des effets indésirables qui diminuent le bénéfice attendu. Le peptide thérapeutique protège le myocarde et améliore les effets de la reperfusion. Cette technologie, brevetée, repose sur un projet collaboratif de plus de 15 ans de l’équipe scientifique.
Recent activities
ApoRepair has been awarded the BOOST INVEST MEDVALLEE label.
ApoRepair has updated its fundraising.
BIC de Montpellier has joined the ApoRepair network.
ApoRepair has updated its fundraising.
ApoRepair has published fundraising documents.
The pitchdeck document has been updated in the dataroom.
Eric Thieulin has joined ApoRepair.
Alexandre Prieur has joined ApoRepair.
Prisc Boisguerin has joined ApoRepair.
Joel Nargeot has joined ApoRepair.